BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15954331)

  • 1. [Mechanism to induce intractable condition of atopic dermatitis].
    Nishioka K
    Nihon Rinsho; 2005 May; 63 Suppl 5():91-5. PubMed ID: 15954331
    [No Abstract]   [Full Text] [Related]  

  • 2. [Skin barrier dysfunction in atopic dermatitis].
    Kawashima M
    Nihon Rinsho; 2005 May; 63 Suppl 5():86-90. PubMed ID: 15954330
    [No Abstract]   [Full Text] [Related]  

  • 3. [Mechanism of pathogenesis in atopic dermatitis].
    Nakahara T; Furue M
    Nihon Rinsho; 2005 May; 63 Suppl 5():80-5. PubMed ID: 15954329
    [No Abstract]   [Full Text] [Related]  

  • 4. Atopic dermatitis.
    Ahuja A; Land K; Barnes CJ
    South Med J; 2003 Nov; 96(11):1068-72. PubMed ID: 14632353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A method to induce stable atopic dermatitis-like symptoms in NC/Nga mice housed with skin-lesioned mice.
    Takano N; Arai I; Kurachi M
    Br J Dermatol; 2006 Mar; 154(3):426-30. PubMed ID: 16445770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperresponsive TH2 cells with enhanced nuclear factor-kappa B activation induce atopic dermatitis-like skin lesions in Nishiki-nezumi Cinnamon/Nagoya mice.
    Tenda Y; Yamashita M; Kimura MY; Hasegawa A; Shimizu C; Kitajima M; Onodera A; Suzuki A; Seki N; Nakayama T
    J Allergy Clin Immunol; 2006 Sep; 118(3):725-33. PubMed ID: 16950294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal skin barrier in the etiopathogenesis of atopic dermatitis.
    Elias PM; Schmuth M
    Curr Opin Allergy Clin Immunol; 2009 Oct; 9(5):437-46. PubMed ID: 19550302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atopic dermatitis: therapeutic concepts evolving from new pathophysiologic insights.
    Jung T; Stingl G
    J Allergy Clin Immunol; 2008 Dec; 122(6):1074-81. PubMed ID: 18992925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased transepidermal water loss and decreased ceramide content in lesional and non-lesional skin of dogs with atopic dermatitis.
    Shimada K; Yoon JS; Yoshihara T; Iwasaki T; Nishifuji K
    Vet Dermatol; 2009 Oct; 20(5-6):541-6. PubMed ID: 20178492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Atopic dermatitis and skin barrier function].
    Tagami H
    Arerugi; 2005 May; 54(5):445-50. PubMed ID: 16043969
    [No Abstract]   [Full Text] [Related]  

  • 11. Listening to mozart reduces allergic skin wheal responses and in vitro allergen-specific IgE production in atopic dermatitis patients with latex allergy.
    Kimata H
    Behav Med; 2003; 29(1):15-9. PubMed ID: 14977243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of Platycodon grandiflorum on T(H)1 and T(H)2 immune responses in a murine model of 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions.
    Kim MS; Hur YG; Kim WG; Park BW; Ahn KS; Kim JJ; Bae H
    Ann Allergy Asthma Immunol; 2011 Jan; 106(1):54-61. PubMed ID: 21195946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide modulation of Th1 and Th2 cytokines in peripheral blood mononuclear leucocytes in atopic dermatitis and non-atopic controls.
    Gordon DJ; Ostlere LS; Holden CA
    Br J Dermatol; 1997 Dec; 137(6):921-7. PubMed ID: 9470908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis.
    Neis MM; Peters B; Dreuw A; Wenzel J; Bieber T; Mauch C; Krieg T; Stanzel S; Heinrich PC; Merk HF; Bosio A; Baron JM; Hermanns HM
    J Allergy Clin Immunol; 2006 Oct; 118(4):930-7. PubMed ID: 17030248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pityrosporum and Candida specific and non-specific humoral, cellular and cytokine responses in atopic dermatitis patients.
    Savolainen J; Lintu P; Kosonen J; Kortekangas-Savolainen O; Viander M; Pène J; Kalimo K; Terho EO; Bousquet J
    Clin Exp Allergy; 2001 Jan; 31(1):125-34. PubMed ID: 11167960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical application of aloperine improves 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions in NC/Nga mice.
    Yuan XY; Ma HM; Li RZ; Wang RY; Liu W; Guo JY
    Eur J Pharmacol; 2011 May; 658(2-3):263-9. PubMed ID: 21371468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between HIV infection and atopic dermatitis.
    Rudikoff D
    Curr Allergy Asthma Rep; 2002 Jul; 2(4):275-81. PubMed ID: 12044260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transepidermal water loss in dry and clinically normal skin in patients with atopic dermatitis.
    Werner Y; Lindberg M
    Acta Derm Venereol; 1985; 65(2):102-5. PubMed ID: 2408409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained exogenous expression of therapeutic levels of IFN-gamma ameliorates atopic dermatitis in NC/Nga mice via Th1 polarization.
    Hattori K; Nishikawa M; Watcharanurak K; Ikoma A; Kabashima K; Toyota H; Takahashi Y; Takahashi R; Watanabe Y; Takakura Y
    J Immunol; 2010 Mar; 184(5):2729-35. PubMed ID: 20107184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A role for T-helper type 1 and type 2 cytokines in the pathogenesis of various human diseases].
    Kasakura S
    Rinsho Byori; 1998 Sep; 46(9):915-21. PubMed ID: 9800477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.